| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |